News
3 Small Biotech Stocks Being Run by Proven Winners
Great leaders are important in any industry, but perhaps they're even more valuable in biotech, where any number of clinical-stage and regulatory obstacles can derail drug research and send share
4 Signs Snap Inc. Needs New Management
Snap (NYSE: SNAP), the maker of Snapchat, recently fell below its IPO price of $17. To make matters worse, the IPO's lead underwriter Morgan Stanley (NYSE: MS) downgraded the stock from overweight to
These 3 Stocks Have Doubled Investors' Money in 2017
The stock market has done well so far in 2017, with gains of almost 10% for the S&P 500 and even greater rises for some other major market benchmarks. A small number of top-performing stocks have done
IBM's New Mainframe Is a Security Powerhouse
While the term "mainframe" may conjure images of room-sized computers cranking out calculations decades ago, International Business Machines' (NYSE: IBM) ever-evolving mainframe systems remain
IBM's New Mainframe Is a Security Powerhouse
While the term "mainframe" may conjure images of room-sized computers cranking out calculations decades ago, International Business Machines' (NYSE: IBM) ever-evolving mainframe systems remain
3 Top Dividend Stocks in Agriculture
Agriculture stocks aren't really popular among income investors, and at first glance, there appear to be decent reasons as to why. Agriculture is, after all, an incredibly boring business, subject to
3 Stocks That Are Ridiculously Cheap Right Now
When a stock goes on sale, and the stock market offers you the chance to buy it for less than it's worth, that's what we investors call a "value stock." But what do you call a stock that's selling for
3 Stocks That Are Ridiculously Cheap Right Now
When a stock goes on sale, and the stock market offers you the chance to buy it for less than it's worth, that's what we investors call a "value stock." But what do you call a stock that's selling for
3 Stocks That Are Ridiculously Cheap Right Now
When a stock goes on sale, and the stock market offers you the chance to buy it for less than it's worth, that's what we investors call a "value stock." But what do you call a stock that's selling for
Qualcomm Investors Need to Be Wary of These Threats
Shares of Qualcomm (NASDAQ: QCOM) have dropped close to their 52-week lows this year as the company has been cornered by a number of problems. The chip giant entered 2017 on the back foot thanks to
Qualcomm Investors Need to Be Wary of These Threats
Shares of Qualcomm (NASDAQ: QCOM) have dropped close to their 52-week lows this year as the company has been cornered by a number of problems. The chip giant entered 2017 on the back foot thanks to
Qualcomm Investors Need to Be Wary of These Threats
Shares of Qualcomm (NASDAQ: QCOM) have dropped close to their 52-week lows this year as the company has been cornered by a number of problems. The chip giant entered 2017 on the back foot thanks to
Will the Drug Pricing Executive Order Help Big Pharma?
The cost of healthcare has climbed at a rate considerably above that of inflation, and high drug costs are a big factor. During his campaign, President Trump indicated that he would take steps to
Will the Drug Pricing Executive Order Help Big Pharma?
The cost of healthcare has climbed at a rate considerably above that of inflation, and high drug costs are a big factor. During his campaign, President Trump indicated that he would take steps to
Will the Drug Pricing Executive Order Help Big Pharma?
The cost of healthcare has climbed at a rate considerably above that of inflation, and high drug costs are a big factor. During his campaign, President Trump indicated that he would take steps to
3 Value Stocks for Sharp Investors
Finding a value stock isn't always as easy as just screening for stocks with low price-to-earnings ratios -- although that's a good place to start. Sharp investors know that sometimes, there's more to
These 3 Stocks Have Lost Over 50% in 2017
Wall Street has been riding high on record performance for major market benchmarks, extending the eight-year-old bull market in 2017. Not every stock has participated in the overall rally, however
1 More Potential Explanation for Intel Corporation's Core X Supply-Demand Imbalance
I recently wrote about the apparent supply-to-demand imbalance of Intel's (NASDAQ: INTC) eight- and 10-core Core X processors for the high-end desktop market. In short, demand seems to be outstripping
1 More Potential Explanation for Intel Corporation's Core X Supply-Demand Imbalance
I recently wrote about the apparent supply-to-demand imbalance of Intel's (NASDAQ: INTC) eight- and 10-core Core X processors for the high-end desktop market. In short, demand seems to be outstripping
1 More Potential Explanation for Intel Corporation's Core X Supply-Demand Imbalance
I recently wrote about the apparent supply-to-demand imbalance of Intel's (NASDAQ: INTC) eight- and 10-core Core X processors for the high-end desktop market. In short, demand seems to be outstripping
1 More Potential Explanation for Intel Corporation's Core X Supply-Demand Imbalance
I recently wrote about the apparent supply-to-demand imbalance of Intel's (NASDAQ: INTC) eight- and 10-core Core X processors for the high-end desktop market. In short, demand seems to be outstripping
Pfizer Is Set to Lose Its No. 1 Spot Among Drugmakers: Here's Why It Doesn't Matter
Pfizer (NYSE: PFE) stands at the top of the mountain when it comes to prescription drug sales. Last year, the big pharma company made $45.9 billion from prescription drugs, well ahead of runners-up
Pfizer Is Set to Lose Its No. 1 Spot Among Drugmakers: Here's Why It Doesn't Matter
Pfizer (NYSE: PFE) stands at the top of the mountain when it comes to prescription drug sales. Last year, the big pharma company made $45.9 billion from prescription drugs, well ahead of runners-up
Is 2018 the Year Virtual Reality Goes Mainstream?
Facebook's (NASDAQ: FB) Oculus is reportedly planning to release a stand-alone virtual reality device next year to retail for just $200. The goal is to push VR into the mainstream.Virtual reality has
Is 2018 the Year Virtual Reality Goes Mainstream?
Facebook's (NASDAQ: FB) Oculus is reportedly planning to release a stand-alone virtual reality device next year to retail for just $200. The goal is to push VR into the mainstream.Virtual reality has